Internal Medicine Alert – April 30, 2008
April 30, 2008
View Issues
-
Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-induced Damage by Rabeprazole
The proton pump inhibitor rabeprazole is said to provide rapid acid inhibition, but clinical implications of this have been uncertain. This study shows that a single dose of rabeprazole 20 mg administered 5 hours before therapeutic dosing of aspirin significantly decreases gastroduodenal damage. -
Traumatic Brain Injury: A Modern Epidemic of "Shell Shock," Revisited
Mild TBI may be associated with brain microhemorrhages and white matter disruption, even with mild or absent symptoms of a postconcussion syndrome. -
Transient Ischemic Attacks: A Neurologic Emergency?
Two recent studies suggest that rapid TIA evaluation and treatment can reduce stroke risk. -
Special Feature: It's the Flu Season! Honey is Sweeter for Cough
A statistically significant improvement in symptoms was observed in the treatment groups, with the honey-child group scoring the best, and the no treatment group doing the most poorly. -
Bendamustine Hydrochloride Injection (Treanda®)
Bendamustine has received FDA approval, after priority review, for the treatment of chronic lymphocytic leukemia. -
Clinical Briefs By Louis Kuritzky, MD
The adenomatous polyp (ADP) is recognized as the primary predecessor of colon cancer (CCA), prompting management strategies to identify and remove ADP.